Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02476513 · ClinicalTrials.gov registry record
Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 18
- Enrollment target
NCT02476513: Completed study, sponsored by University of Alabama at Birmingham.
NCT02476513 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02476513 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
In this study,the investigators will evaluate participants that have clinical features associated with an increased risk of esophageal disorders.The investigators will also see if there is a positive association of esophageal disorders in men,40-60 with or without abdominal obesity in the diagnosis of the following diseases; Gastroesophageal reflux disease, Barrett Esophagus and Esophageal Adenocarcinoma. The investigators hypothesize that most obese patients referred for Esophagogastroduodenoscopy will exhibit esophageal disorders. Since currently the rates of obesity and adenocarcinoma of the esophagus have increased significantly over the past 15 years, the investigators hope to find biochemical markers (i.e. pro-inflammatory mediators) in the esophagus. The investigators hope these samples will lead us to a differential expression of molecular markers and inflammatory mediators in the varying degrees of esophageal disorder
Primary Outcome
We will use data collected from the waist measurements and the measurement compiled from the CT scan of the abdomen. The correlate it with the actual tissue markers(if any) found from the pathologists review.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-07 |
What the finished NCT02476513 record still lists
NCT02476513 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02476513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02476513 about?
NCT02476513 is a clinical study titled "Clinical and Molecular Assessment of Men With High Risk for Esophageal Disorders". In this study,the investigators will evaluate participants that have clinical features associated with an increased risk of esophageal disorders.The investigators will also see if there is a positive association of esophageal disorders in men,40-60 with or without abdominal obesity in the diagnosis ...
What is the current status of trial NCT02476513?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2014-02. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT02476513?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia